XWELL, Inc. (XWEL) Stock Score, Valuation & Financial Research
XWELL, Inc. is in the Consumer Cyclical sector and Personal Products & Services industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 24/100.
Quick answer for XWEL
XWELL, Inc. currently has a Wall Street Score of 24/100. The stored market price is $0.96. Its financial score is 13/100. Its valuation score is 0/100. These figures are a research snapshot, not a buy or sell recommendation.
What XWELL, Inc. does
XWELL Inc. functions as a health and wellness services provider, primarily operating within airports. The company delivers its diverse offerings through various brands, including XpresSpa, XpresTest, Treat, and HyperPointe. Its core services feature a range of spa treatments such as massages, nail care, and skincare, further complemented by the sale of spa, travel, and general retail merchandise. Beyond relaxation services, XWELL also manages dedicated wellness centers. These facilities provide crucial health diagnostic services, encompassing COVID-19 screening and testing, rapid tests for various communicable diseases like influenza, RSV, and different flu strains (A&B), alongside seasonal flu vaccinations and other medical diagnostic procedures. To enhance accessibility for the traveling public, the company utilizes an integrated digital platform and a tailored retail selection. As of
XWEL financial snapshot
- Wall Street Score:
- 24/100
- Current price:
- $0.96
- Market capitalization:
- $7.6M
- Revenue:
- $28.8M
- Net income:
- $-23.4M
- Free cash flow:
- $-11.7M
- Cash:
- $16.8M
- Total debt:
- $8.3M
- EPS:
- -5.08
- Financial score:
- 13/100
- Valuation score:
- 0/100
- Revenue score:
- 20/100
What stands out
- Reported year-over-year revenue growth is -0.0%.
- Free cash flow is $-11.7M, showing cash burn in the current stored period.
- The balance sheet shows $16.8M of cash versus $8.3M of total debt, leaving more cash than debt.
What the numbers mean
Its current valuation score is 0/100, which Wall Street Score classifies as weak within the model's valuation framework.
The financial score is 13/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-07-24.
How to research XWEL
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.